Apramycin is an aminoglycoside antibiotic and has a bactericidal action against many gram-negative bacteria. Apramycin is a structurally unique antibiotic that contains a bicyclic sugar moiety and a monosubstituted deoxystreptamine. It is not approved for use in humans.
Synonyms: Apramycinum Nebramycin II 4-O-((8R)-2-amino-8-O-(4-amino-4-deoxy-α-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-α-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-D-streptamine Apramycin Apramycine 4-O-(3α-amino-6α-((4-amino-4-deoxy-α-D-glucopyranosyl)oxy)-2,3,4,5aβ,6,7,8,8aα-octahydro-8β-hydroxy-7β-(methylamino)pyrano(3,2-b)pyran-2α-yl)-2-deoxy-D-streptamine Apramicina
Term information
- KEGG Compound:C01555
- ChEMBL:CHEMBL1230961
- Therapeutic Targets Database:DNC000243
- CAS:37321-09-8
- PubChem Compound:3081545
- ChemSpider:2339128
- PDB:AM2
- Drugs Product Database (DPD):11216
- PubChem Substance:46509143
- Wikipedia:Apramycin
- KEGG Drug:D02322
- ChEBI:2790
KEGG Drug:D02322
Drugs Product Database (DPD):11216
ChEMBL:CHEMBL1230961
ChEBI:2790
PDB:AM2
Wikipedia:Apramycin
KEGG Compound:C01555
PubChem Compound:3081545
CAS:37321-09-8
Therapeutic Targets Database:DNC000243
ChemSpider:2339128
PubChem Substance:46509143